He is a hematologist and member of the Lymphoma Program and the Autologous Blood and Marrow Transplant program. Dr. Kuruvilla’s research interests include novel drug development in lymphoid malignancies incorporating translational research and clinical trials in these disorders. He is a member of the Hematology Disease Site Group of the Canadian Trials Group (CCTG formerly NCIC CTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.